ABSTRACT
Cyclase-associated protein 1 (CAP1) is a conserved actin-regulating protein that enhances actin filament dynamics and also regulates adhesion in mammalian cells. We previously found that phosphorylation at the Ser307/Ser309 tandem site controls its association with cofilin and actin and is important for CAP1 to regulate the actin cytoskeleton. Here, we report that transient Ser307/Ser309 phosphorylation is required for CAP1 function in both actin filament disassembly and cell adhesion. Both the phosphomimetic and the nonphosphorylatable CAP1 mutant, which resist transition between phosphorylated and dephosphorylated forms, had defects in rescuing the reduced rate of actin filament disassembly in the CAP1 knockdown HeLa cells. The phosphorylation mutants also had defects in alleviating the elevated focal adhesion kinase (FAK) activity and the enhanced focal adhesions in the knockdown cells. In dissecting further phosphoregulatory cell signals for CAP1, we found that cyclin-dependent kinase 5 (CDK5) phosphorylates both Ser307 and Ser309 residues, whereas cAMP signaling induces dephosphorylation at the tandem site, through its effectors protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac). No evidence supports an involvement of activated protein phosphatase in executing the dephosphorylation downstream from cAMP, whereas preventing CAP1 from accessing its kinase CDK5 appears to underlie CAP1 dephosphorylation induced by cAMP. Therefore, this study provides direct cellular evidence that transient phosphorylation is required for CAP1 functions in both actin filament turnover and adhesion, and the novel mechanistic insights substantially extend our knowledge of the cell signals that function in concert to regulate CAP1 by facilitating its transient phosphorylation.
ACKNOWLEDGMENTS
We thank members of the Ph.D. dissertation committee for H.Z. and the Zhou laboratory for helpful discussions. We also thank Daniel Altschuler (University of Pittsburg) for the gift of Epac plasmids.
Research reported in this publication was supported by the National Institute Of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under award number R15GM134488 (to G.-L.Z). G.-L.Z. was also supported by an Institutional Development Award (IDeA) grant from the NIGMS of the NIH (grant number P20GM103429). S.O. is supported by a grant from the NIH (grant number R01 AR48615).
We declare no potential conflict of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding sponsor had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision to publish the results.
H.Z. conceived the study, designed and performed the majority of the experiments, analyzed the data, and contributed to figure organization and writing of the manuscript. A.R., U.K., Y.X., J.X., and J.Y.X. performed experiments and analyzed data. J.X. contributed to organizing figures. S.O. contributed to the design of experiments and edited the manuscript. T.K. made overall contributions to the project and edited the manuscript. G.-L.Z. conceived the study, directed the project, organized the figures, and wrote the manuscript.